This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, The Trustees of Boston College, The Broad Institute, Inc.. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Roxbury, MA (US) (2015 - 2017)
- Quincy, MA (US) (2018)
Company Filing History:
5 out of 8,594 
3 out of 117 
2 out of 488 
Years Active: 2015-2018
Title: Miao Yu: Innovator in Scavenger Receptor Inhibition
Introduction
Miao Yu is a prominent inventor based in West Roxbury, MA, with a significant contribution to the field of biochemistry and pharmacology. He holds a total of five patents, showcasing his innovative approach to developing compounds that target specific biological receptors.
Latest Patents
Miao Yu's latest patents include "Thiazole-based inhibitors of scavenger receptor BI" and "Heterocycle-bisamide inhibitors of scavenger receptor BI." These applications describe compounds and methods that can inhibit Scavenger receptor class B, type I (SR-BI) activity. The compounds and methods can be utilized to mediate high-density lipoprotein (HDL) lipid uptake and treat hepatitis C viral infections. The detailed chemical formulas and structures of these compounds highlight their potential therapeutic applications.
Career Highlights
Throughout his career, Miao Yu has worked with esteemed institutions such as the Massachusetts Institute of Technology and the Trustees of Boston College. His work has significantly advanced the understanding of lipid metabolism and its implications for viral infections.
Collaborations
Miao Yu has collaborated with notable colleagues, including Amir H. Hoveyda and Chenbo Wang. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Miao Yu's contributions to the field of biochemistry through his innovative patents and collaborations underscore his role as a leading inventor. His work continues to impact the development of therapeutic strategies for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile